Welcome to our dedicated page for Fingermotion SEC filings (Ticker: FNGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking FingerMotion’s fast-moving telecom deals and mobile top-up volumes across 200-page disclosures can feel overwhelming. Exchange-rate nuances, carrier renewal clauses and segment margins are buried deep inside each report, making it hard to spot opportunities—or red flags—quickly.
Stock Titan’s AI solves that problem. Our engine breaks down every FingerMotion SEC filing into plain language highlights. Need the latest FingerMotion quarterly earnings report 10-Q filing? We surface revenue per mobile user and cash flow in seconds. Curious about FingerMotion insider trading Form 4 transactions? Real-time alerts show which executives bought shares, giving you context before the market reacts.
All filing types are here with minute-by-minute EDGAR updates:
- 10-K: Get the FingerMotion annual report 10-K simplified—AI pulls out carrier contract risks and big-data license milestones.
- 10-Q: Dive into quarter-over-quarter recharge growth with our FingerMotion earnings report filing analysis.
- 8-K: Material events—from new telecom partnerships to capital raises—are FingerMotion 8-K material events explained in one paragraph.
- Form 4: Monitor FingerMotion executive stock transactions Form 4 with FingerMotion Form 4 insider transactions real-time dashboards.
- DEF 14A: The FingerMotion proxy statement executive compensation section details stock option grants and performance metrics, all summarized clearly.
Whether you’re understanding FingerMotion SEC documents with AI for compliance checks or scanning for growth catalysts, our platform delivers the insights you need—without the jargon.
Milestone Pharmaceuticals Inc. (MIST) – Form 4 insider transaction
On 11 July 2025, President, CEO and Director Joseph Oliveto purchased 66,666 issuer Units at $1.50 per Unit. Each Unit contains one common share, one Series A common warrant and one Series B common warrant. Consequently:
- Common shares acquired: 66,666 (A-coded). Mr. Oliveto now directly owns 347,221 common shares.
- Series A warrants: 66,666 warrants, exercise price $1.50, fully vested, expire 11 July 2026.
- Series B warrants: 66,666 warrants, exercise price $1.875, fully vested, expire 11 July 2030.
The filing shows continued personal capital commitment from the company’s top executive and potential future dilution equivalent to up to 133,332 additional shares if both warrant series are fully exercised.
FAQ
What is the current stock price of Fingermotion (FNGR)?
What is the market cap of Fingermotion (FNGR)?
What is the core business of FingerMotion Inc?
How does the Pigeonhole Integration System (PIS) work?
Which industries does FingerMotion serve?
How does the company ensure secure and reliable transactions?
What differentiates FingerMotion from its competitors?
How does FingerMotion leverage big data and cloud services?
What role do SMS and MMS services play in FingerMotion's offerings?
How is FingerMotion involved in emergency response solutions?
